News

First demonstration of a melanoma arising from a single cell.

An international consortium of scientists has identified a stretch of chromosome that is associated with responsiveness to the mood-stabilizing medication lithium among patients with bipolar disorder.

Swift Biosciences and SeraCare Life Sciences have announced a partnership to accelerate development of a novel circulating tumor DNA reference material.

A new study addresses a central challenge of transgenic plant development: how to reliably evaluate whether genetic material has been successfully introduced.

On Tuesday 26 January, three scientists from The Genome Analysis Centre (TGAC) helped kick-off the first installment of ‘PubhD’ at the Cellar House in Eaton, Norwich.

Obesity can sometimes be shut down.

Startup develops more cost-effective test for assessing how cells respond to chemicals.

Looking at a brain tumor’s epigenetic signature may help guide therapy.

DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage.

Illumina, Inc. has announced that Dr. Frances Arnold has joined the company’s Board of Directors. Dr. Arnold manages a research group at the California Institute of Technology and is the Director of the Donna and Benjamin M. Rosen Bioengineering Center.